A Real World Assessment of the Efficacy and Safety of Switching from TDF to TAF in Treatment Experienced Patients with HIV Infection

Authors

Jaclyn O'Connor, PharmD Candidate, Thomas Jefferson UniversityFollow
Kaitlin N. Sassa, PharmD, Thomas Jefferson UniversityFollow
Jason J. Schafer, PharmD, MPH, BCPS AQ-ID, BCIDP, AAHIVP, Thomas Jefferson UniversityFollow

Files

Description

Objective

• The primary objective of this study was to determine if patients maintain viral suppression after switching from TDF to TAF
• The secondary objective was to assess changes in renal function and serum cholesterol levels

Publication Date

12-4-2019

Keywords

HIV, tenofovir, weight gain, cholesterol, cardiovascular disease

Disciplines

Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences

Comments

Presented at the 2019 American Society of Health-System Pharmacists Midyear Clinical Meeting

Recommended Citation

O'Connor, PharmD Candidate, Jaclyn; Sassa, PharmD, Kaitlin N.; and Schafer, PharmD, MPH, BCPS AQ-ID, BCIDP, AAHIVP, Jason J., "A Real World Assessment of the Efficacy and Safety of Switching from TDF to TAF in Treatment Experienced Patients with HIV Infection" (2019). College of Pharmacy Posters. 19.
https://jdc.jefferson.edu/pharmacyposters/19